Centrally and peripherally acting peptides supporting libido, arousal and sexual function across both sexes.
Supports sexual desire in women (FDA-approved for HSDD)
Melanocortin-4 receptor agonist. Centrally mediated sexual arousal pathway.
FDA-approved (Vyleesi).
Cautions: Hypertension: transient BP rise · Cardiovascular disease
Supports libido and arousal
Intranasal melanocortin-4 receptor agonist for sexual arousal signaling; gentler onset than injection.
Compounded off-label.
Cautions: Transient blood pressure rise · Cardiovascular disease: clinician judgment
Supports natural LH/FSH production
Decapeptide acting on KISS1R neurons to drive endogenous GnRH and the downstream HPG axis.
Research / compounding only.
Cautions: Investigational · Endocrine workup required
Every protocol is reviewed by an independent, licensed physician before any recommendation is issued.
We only prescribe therapies that are legally available where you live, through compliant pharmacies.
Your medical intake and blood panel are screened for conditions that would make a peptide unsafe.
Protocols are adjusted based on objective lab change. If a marker is not improving, we change the plan.
The €90 intake returns a clinician-reviewed brief in 48 hours. Full protocol · €320.
Start assessment →